Helicobacter Pylori Testing Market

Market Insights on Helicobacter Pylori Testing covering sales outlook, demand forecast & up-to-date key trends

Helicobacter Pylori Testing Market By Test Type, End User & Region - Forecast 2022 – 2032

Helicobacter Pylori Testing Market Outlook (2022-2032)

[301 Pages Report] The global helicobacter pylori testing market is expected to accumulate US$ 173.1 Million in value by 2022-end. During the forecast period ranging from 2022 to 2032, a CAGR worth 7.4% has been projected for the market, with an expected closing value worth US$ 380.3 Million. During the 2016-2021 historical period, the industry grew at a value CAGR worth 6.2%.

“Growing awareness of immunodiagnostics in developed countries like United States & Germany and increasing product approvals boost the demand for Helicobacter Pylori Testing.”

Attributes	Key Statistics
Global Helicobacter Pylori Testing Market CAGR (2022-2032)	7.4%
Anticipated Market Value (2022)	US$ 173.1 Million
Global Helicobacter Pylori Testing Market (2032)	US$ 380.3 Million
Global Helicobacter Pylori Testing Market Attraction	People's growing awareness of immunodiagnostics, rapid advances in technology and innovation, and increasing product approvals are anticipated to propel the global helicobacter pylori testing market forward.

Helicobacter pylori testing is used to diagnose Helicobacter pylori infections in the upper small intestine and stomach. The helicobacter pylori test is also used to evaluate treatment efficacy. Peptic ulcers, stomach (gastric) cancer, and chronic gastritis can all be caused by helicobacter pylori.

Helicobacter pylori testing is used to determine whether a helicobacter pylori infection is causing an ulcer. There are various types of helicobacter pylori testing obtainable. Some of them require a stool or breath sample, while others are more invasive and require a tissue sample obtained via endoscopy.

The bacteria Helicobacter pylori grows in the digestive tract and has a proclivity to attack the stomach lining. Helicobacter pylori infections are usually harmless, but they are responsible for the vast majority of the small intestine and stomach ulcers. Because it is the most common illness in humans, early detection is critical. According to CDC research, Helicobacter pylori causes more than 90% of duodenal ulcers and up to 80% of gastric ulcers.

Customize this Report

Let us know your requirement to get
100% FREE customization

Customize Now

What are the Factors Propelling the Global Helicobacter Pylori Testing Market?

The global helicobacter pylori testing industry is poised to increase consistently over the forecast period due to an aging population and an increase in the prevalence of infectious diseases and gastritis. People's growing awareness of immunodiagnostics, rapid advances in technology and innovation, and increasing product approvals are anticipated to propel the global helicobacter pylori testing market forward.

The advancement of newer innovations to enhance accuracy and precision has stemmed from a preference for non-invasive testing. Furthermore, non-invasive tests allow for multiple sample screenings at the same time, which a?ects its acceptance rate. Reduced time, reduction of other infections during invasive testing, and less severe pain will all encourage more people to use non-invasive testing.

What are the Factors Hampering the Global Helicobacter Pylori Testing Market?

However, high test costs and a lack of awareness about helicobacter pylori testing are major factors restricting the growth of the global helicobacter pylori testing market.

Furthermore, underdeveloped and developing countries face challenges related to a lack of healthcare resources. This results in limited access to healthcare services with insufficient facilities, which increases the likelihood of a lack of knowledge about such diseases and their diagnosis.

Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Why is North America Emerging as an Opportunistic Helicobacter Pylori Testing Market?

The market for Helicobacter pylori testing in North America is expected to take a turn for the better, attributed to the growing prevalence of H. pylori infections, rising awareness about disease diagnosis and treatment, and government initiatives to eradicate the incidence of infections.

The bacteria pose a high risk of stomach cancer, contributing to the existing disease burden, and are thus bound to grow the associated incidence and mortality among African Americans in the United States. Furthermore, advances in diagnostic technology and the inclusion of advanced healthcare infrastructure will fuel the country's growth. According to Future Market Insights, North America is likely to account for a 36.4% market share as of 2022.

According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), approximately half of people over the age of 60 and 20% of people under the age of 40 are infected with Helicobacter Pylori in the United States. Furthermore, technological advancements in Helicobacter pylori diagnostics, as well as the presence of a well-established healthcare infrastructure, are fuelling the market's growth to a large extent.

Why is the Demand for Helicobacter Pylori Testing Burgeoning in Europe?

Europe is thought to have the second-largest H. pylori testing market share, accumulating 32% revenue as of 2022. An important factor is the widespread utilization of antibiotics in many countries. In addition, rising investments and the presence of various key players are being evaluated to drive market growth.

The European market for helicobacter pylori testing is expected to be the second largest. The increasing patient pool intent on early detection of helicobacter pylori infection to avoid peptic ulcers is expected to aid market growth in the European region.

The role of H pylori in gastritis, peptic ulcers, and gastric cancer is now established, but research currently underway into possible associations with cardiovascular disease and several other conditions could guarantee a massive market in Europe for H pylori diagnostic tests and antimicrobial eradication therapy.

According to the National Institute for Health Research, the ubiquity of Helicobacter pylori is intense in most countries, including North European populations, where approximately one-third of adults are still infected, whereas, in South America, Asia, and south and east Europe, the prevalence is greater than 50%. Furthermore, Helicobacter pylori remain highly prevalent in immigrants from Helicobacter pylori-endemic countries in Europe. These factors are anticipated to propel the global helicobacter pylori testing market forward in Europe.

Become a MarketNgage Insider

A unified Market Research Subscription Platform, built for today's disparate research needs.

Sign-Up

How Start-ups are Adding Value to the Global Helicobacter Pylori Testing Market

The swelling dispersion of start-ups in the Helicobacter Pylori Testing market has improved the product quality and expanded global sales. Besides, to gain a competitive edge, new start-ups are working on innovative developments and launching new products such as:

In 2010, Sekisui Diagnostics (UK) Ltd was established. The company's product line includes medical, surgical, ophthalmic, and veterinary instruments and apparatus. OSOM® H. pylori Test For the qualitative detection of H. pylori antibodies in serum, plasma, or whole blood as an aid in the diagnosis of H. pylori infection was recently launched by the company.

Who are the Key Players in the Global Helicobacter Pylori Testing Packaging Market?

Some key players in the Helicobacter Pylori Testing packaging market are Abbott, ADI/American Diagnostica, Agilent Technologies, Bio-Rad Laboratories, Inc., Helena Laboratories, Horiba, Takara Bio, EKF Diagnostics, Exalenz Bioscience Ltd. and Sekisui Diagnostics, LLC. Key development in the Helicobacter Pylori Testing Packaging market is as follows:

Horiba launched the Horiba ABX Micros ESV 60 Hematology Analyzer in November 2021, which is the Gold Standard of Veterinary Hematology Testing for 11 animal species.

In July 2022, Bio Rad released Platelia H. pylori IgG, an immuno-enzymatic assay for qualitative determination of IgG antibodies. Serology provides a non-invasive, sensitive, and simple method for determining H. pylori infection. Platelia H. pylori IgG is an immunoenzymatic assay for determining the quality of IgG antibodies.

Report Scope

Report Attribute	Details
Growth Rate	CAGR of 7.4% from 2022 to 2032
Market Value in 2022	US$ 173.1 Million
Market Value in 2032	US$ 380.3 Million
Base Year for Estimation	2021
Historical Period	2016-2021
Forecast Period	2022-2032
Quantitative Units	Revenue in US$ Million and CAGR from 2022-2032
Report Coverage	Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis
Segments Covered	Test Type End Use Region
Regions Covered	North America Latin America Europe Asia Pacific Middle East and Africa
Key Countries Profiled	U.S Canada Brazil Mexico Germany U.K France Spain Italy China Japan South Korea Malaysia Singapore Australia New Zealand GCC South Africa Israel
Key Companies Profiled	Abbott Laboratories ADI/American Diagnostica Agilent Technologies Bio-Rad Laboratories, Inc. Helena Laboratories Horiba Takara Bio EKF Diagnostics Exalenz Bioscience Ltd. Sekisui Diagnostics, LLC
Customization	Available Upon Request

Key Segments Covered in the Helicobacter Pylori Testing Industry Survey

Helicobacter Pylori Testing Market by Test Type:

Helicobacter Pylori Testing with Endoscopy
- Histology
- Rapid Urease Testing
- PCR (Polymerase Chain Reaction)
- Culture Testing
Helicobacter Pylori Testing without Endoscopy
- Stool/Faecal Antigen Test
- Urea Breath Test
- H. Pylori Antibody Testing

Helicobacter Pylori Testing Market by End User:

Helicobacter Pylori Testing in Hospitals
Helicobacter Pylori Testing in Private Labs
Helicobacter Pylori Testing in Public Health Labs
Helicobacter Pylori Testing in Physician Offices

Helicobacter Pylori Testing Market by Region:

North America Helicobacter Pylori Testing Market
Latin America Helicobacter Pylori Testing Market
Europe Helicobacter Pylori Testing Market
Asia Pacific Helicobacter Pylori Testing Market
Middle East & Africa Helicobacter Pylori Testing Market

Frequently Asked Questions

What is the estimated market value of the helicobacter pylori testing market in 2022?

The global helicobacter pylori testing market is likely to value at US$ 173.1 Million in 2022.

What is the projected CAGR of the helicobacter pylori testing market until 2032?

The helicobacter pylori testing market is estimated to grow at a CAGR of 7.4% from 2022 to 2032.

What is the expected market value of the global helicobacter pylori testing market by 2032?

The helicobacter pylori testing market is predicted to procure US$ 380.3 Million by 2032.

Table of Content

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand-side Trends

1.3. Supply-side Trends

1.4. Technology Roadmap Analysis

1.5. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

3. Market Background

3.1. Market Dynamics

3.1.1. Drivers

3.1.2. Restraints

3.1.3. Opportunity

3.1.4. Trends

3.2. Scenario Forecast

3.2.1. Demand in Optimistic Scenario

3.2.2. Demand in Likely Scenario

3.2.3. Demand in Conservative Scenario

3.3. Opportunity Map Analysis

3.4. Investment Feasibility Matrix

3.5. PESTLE and Porter’s Analysis

3.6. Regulatory Landscape

3.6.1. By Key Regions

3.6.2. By Key Countries

3.7. Regional Parent Market Outlook

4. Global Market Analysis 2016-2021 and Forecast, 2022-2032

4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021

4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032

4.2.1. Y-o-Y Growth Trend Analysis

4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2016-2021 and Forecast 2022-2032, By Test Type

5.1. Introduction / Key Findings

5.2. Historical Market Size Value (US$ Mn) Analysis By Test Type, 2017-2021

5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Test Type, 2022-2032

5.3.1. With Endoscopy

5.3.2. Histology

5.3.3. Rapid Urease Testing

5.3.4. Culture

5.3.5. PCR (Polymerase Chain Reaction)

5.3.6. Without Endoscopy

5.3.7. Stool/Faecal Antigen Test

5.3.8. Urea Breath Test

5.3.9. H. Pylori Antibody Testing

5.4. Y-o-Y Growth Trend Analysis By Test Type, 2017-2021

5.5. Absolute $ Opportunity Analysis By Test Type, 2022-2032

6. Global Market Analysis 2016-2021 and Forecast 2022-2032, By End User

6.1. Introduction / Key Findings

6.2. Historical Market Size Value (US$ Mn) Analysis By End User, 2017-2021

6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End User, 2022-2032

6.3.1. Hospitals

6.3.2. Private Labs

6.3.3. Public Health Labs

6.3.4. Physician Offices

6.4. Y-o-Y Growth Trend Analysis By End User, 2017-2021

6.5. Absolute $ Opportunity Analysis By End User, 2022-2032

7. Global Market Analysis 2016-2021 and Forecast 2022-2032, By Region

7.1. Introduction

7.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021

7.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032

7.3.1. North America

7.3.2. Latin America

7.3.3. Europe

7.3.4. Asia Pacific

7.3.5. MEA

7.4. Market Attractiveness Analysis By Region

8. North America Market Analysis 2016-2021 and Forecast 2022-2032, By Country

8.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

8.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

8.2.1. By Country

8.2.1.1. U.S.

8.2.1.2. Canada

8.2.2. By Test Type

8.2.3. By End User

8.3. Market Attractiveness Analysis

8.3.1. By Country

8.3.2. By Test Type

8.3.3. By End User

8.4. Key Takeaways

9. Latin America Market Analysis 2016-2021 and Forecast 2022-2032, By Country

9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

9.2.1. By Country

9.2.1.1. Brazil

9.2.1.2. Mexico

9.2.1.3. Rest of Latin America

9.2.2. By Test Type

9.2.3. By End User

9.3. Market Attractiveness Analysis

9.3.1. By Country

9.3.2. By Test Type

9.3.3. By End User

9.4. Key Takeaways

10. Europe Market Analysis 2016-2021 and Forecast 2022-2032, By Country

10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

10.2.1. By Country

10.2.1.1. Germany

10.2.1.2. U.K.

10.2.1.3. France

10.2.1.4. Spain

10.2.1.5. Italy

10.2.1.6. Rest of Europe

10.2.2. By Test Type

10.2.3. By End User

10.3. Market Attractiveness Analysis

10.3.1. By Country

10.3.2. By Test Type

10.3.3. By End User

10.4. Key Takeaways

11. Asia Pacific Market Analysis 2016-2021 and Forecast 2022-2032, By Country

11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

11.2.1. By Country

11.2.1.1. China

11.2.1.2. Japan

11.2.1.3. South Korea

11.2.1.4. India

11.2.1.5. Malaysia

11.2.1.6. Singapore

11.2.1.7. Australia

11.2.1.8. New Zealand

11.2.1.9. Rest of APAC

11.2.2. By Test Type

11.2.3. By End User

11.3. Market Attractiveness Analysis

11.3.1. By Country

11.3.2. By Test Type

11.3.3. By End User

11.4. Key Takeaways

12. MEA Market Analysis 2016-2021 and Forecast 2022-2032, By Country

12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

12.2.1. By Country

12.2.1.1. GCC Countries

12.2.1.2. South Africa

12.2.1.3. Israel

12.2.1.4. Rest of MEA

12.2.2. By Test Type

12.2.3. By End User

12.3. Market Attractiveness Analysis

12.3.1. By Country

12.3.2. By Test Type

12.3.3. By End User

12.4. Key Takeaways

13. Key Countries Market Analysis

13.1. U.S.

13.1.1. Pricing Analysis

13.1.2. Market Share Analysis, 2021

13.1.2.1. By Test Type

13.1.2.2. By End User

13.2. Canada

13.2.1. Pricing Analysis

13.2.2. Market Share Analysis, 2021

13.2.2.1. By Test Type

13.2.2.2. By End User

13.3. Brazil

13.3.1. Pricing Analysis

13.3.2. Market Share Analysis, 2021

13.3.2.1. By Test Type

13.3.2.2. By End User

13.4. Mexico

13.4.1. Pricing Analysis

13.4.2. Market Share Analysis, 2021

13.4.2.1. By Test Type

13.4.2.2. By End User

13.5. Germany

13.5.1. Pricing Analysis

13.5.2. Market Share Analysis, 2021

13.5.2.1. By Test Type

13.5.2.2. By End User

13.6. U.K.

13.6.1. Pricing Analysis

13.6.2. Market Share Analysis, 2021

13.6.2.1. By Test Type

13.6.2.2. By End User

13.7. France

13.7.1. Pricing Analysis

13.7.2. Market Share Analysis, 2021

13.7.2.1. By Test Type

13.7.2.2. By End User

13.8. Spain

13.8.1. Pricing Analysis

13.8.2. Market Share Analysis, 2021

13.8.2.1. By Test Type

13.8.2.2. By End User

13.9. Italy

13.9.1. Pricing Analysis

13.9.2. Market Share Analysis, 2021

13.9.2.1. By Test Type

13.9.2.2. By End User

13.10. China

13.10.1. Pricing Analysis

13.10.2. Market Share Analysis, 2021

13.10.2.1. By Test Type

13.10.2.2. By End User

13.11. Japan

13.11.1. Pricing Analysis

13.11.2. Market Share Analysis, 2021

13.11.2.1. By Test Type

13.11.2.2. By End User

13.12. South Korea

13.12.1. Pricing Analysis

13.12.2. Market Share Analysis, 2021

13.12.2.1. By Test Type

13.12.2.2. By End User

13.13. Malaysia

13.13.1. Pricing Analysis

13.13.2. Market Share Analysis, 2021

13.13.2.1. By Test Type

13.13.2.2. By End User

13.14. Singapore

13.14.1. Pricing Analysis

13.14.2. Market Share Analysis, 2021

13.14.2.1. By Test Type

13.14.2.2. By End User

13.15. Australia

13.15.1. Pricing Analysis

13.15.2. Market Share Analysis, 2021

13.15.2.1. By Test Type

13.15.2.2. By End User

13.16. New Zealand

13.16.1. Pricing Analysis

13.16.2. Market Share Analysis, 2021

13.16.2.1. By Test Type

13.16.2.2. By End User

13.17. GCC Countries

13.17.1. Pricing Analysis

13.17.2. Market Share Analysis, 2021

13.17.2.1. By Test Type

13.17.2.2. By End User

13.18. South Africa

13.18.1. Pricing Analysis

13.18.2. Market Share Analysis, 2021

13.18.2.1. By Test Type

13.18.2.2. By End User

13.19. Israel

13.19.1. Pricing Analysis

13.19.2. Market Share Analysis, 2021

13.19.2.1. By Test Type

13.19.2.2. By End User

14. Market Structure Analysis

14.1. Competition Dashboard

14.2. Competition Benchmarking

14.3. Market Share Analysis of Top Players

14.3.1. By Regional

14.3.2. By Test Type

14.3.3. By End User

15. Competition Analysis

15.1. Competition Deep Dive

15.1.1. Abbott

15.1.1.1. Overview

15.1.1.2. Product Portfolio

15.1.1.3. Profitability by Market Segments

15.1.1.4. Sales Footprint

15.1.1.5. Strategy Overview

15.1.1.5.1. Marketing Strategy

15.1.2. ADI/American Diagnostica

15.1.2.1. Overview

15.1.2.2. Product Portfolio

15.1.2.3. Profitability by Market Segments

15.1.2.4. Sales Footprint

15.1.2.5. Strategy Overview

15.1.2.5.1. Marketing Strategy

15.1.3. Agilent Technologies

15.1.3.1. Overview

15.1.3.2. Product Portfolio

15.1.3.3. Profitability by Market Segments

15.1.3.4. Sales Footprint

15.1.3.5. Strategy Overview

15.1.3.5.1. Marketing Strategy

15.1.4. Bio-Rad Laboratories Inc.

15.1.4.1. Overview

15.1.4.2. Product Portfolio

15.1.4.3. Profitability by Market Segments

15.1.4.4. Sales Footprint

15.1.4.5. Strategy Overview

15.1.4.5.1. Marketing Strategy

15.1.5. Helena Laboratories

15.1.5.1. Overview

15.1.5.2. Product Portfolio

15.1.5.3. Profitability by Market Segments

15.1.5.4. Sales Footprint

15.1.5.5. Strategy Overview

15.1.5.5.1. Marketing Strategy

15.1.6. Horiba

15.1.6.1. Overview

15.1.6.2. Product Portfolio

15.1.6.3. Profitability by Market Segments

15.1.6.4. Sales Footprint

15.1.6.5. Strategy Overview

15.1.6.5.1. Marketing Strategy

15.1.7. Takara Bio

15.1.7.1. Overview

15.1.7.2. Product Portfolio

15.1.7.3. Profitability by Market Segments

15.1.7.4. Sales Footprint

15.1.7.5. Strategy Overview

15.1.7.5.1. Marketing Strategy

15.1.8. EKF Diagnostics

15.1.8.1. Overview

15.1.8.2. Product Portfolio

15.1.8.3. Profitability by Market Segments

15.1.8.4. Sales Footprint

15.1.8.5. Strategy Overview

15.1.8.5.1. Marketing Strategy

15.1.9. Exalenz Bioscience Ltd.

15.1.9.1. Overview

15.1.9.2. Product Portfolio

15.1.9.3. Profitability by Market Segments

15.1.9.4. Sales Footprint

15.1.9.5. Strategy Overview

15.1.9.5.1. Marketing Strategy

15.1.10. Sekisui Diagnostics

15.1.10.1. Overview

15.1.10.2. Product Portfolio

15.1.10.3. Profitability by Market Segments

15.1.10.4. Sales Footprint

15.1.10.5. Strategy Overview

15.1.10.5.1. Marketing Strategy

16. Assumptions & Acronyms Used

17. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

Customize Now

List of Tables

Table 1: Global Market Value (US$ Mn) Forecast by Region, 2016-2032

Table 2: Global Market Value (US$ Mn) Forecast by Test Type, 2016-2032

Table 3: Global Market Value (US$ Mn) Forecast by End User, 2016-2032

Table 4: North America Market Value (US$ Mn) Forecast by Country, 2016-2032

Table 5: North America Market Value (US$ Mn) Forecast by Test Type, 2016-2032

Table 6: North America Market Value (US$ Mn) Forecast by End User, 2016-2032

Table 7: Latin America Market Value (US$ Mn) Forecast by Country, 2016-2032

Table 8: Latin America Market Value (US$ Mn) Forecast by Test Type, 2016-2032

Table 9: Latin America Market Value (US$ Mn) Forecast by End User, 2016-2032

Table 10: Europe Market Value (US$ Mn) Forecast by Country, 2016-2032

Table 11: Europe Market Value (US$ Mn) Forecast by Test Type, 2016-2032

Table 12: Europe Market Value (US$ Mn) Forecast by End User, 2016-2032

Table 13: Asia Pacific Market Value (US$ Mn) Forecast by Country, 2016-2032

Table 14: Asia Pacific Market Value (US$ Mn) Forecast by Test Type, 2016-2032

Table 15: Asia Pacific Market Value (US$ Mn) Forecast by End User, 2016-2032

Table 16: MEA Market Value (US$ Mn) Forecast by Country, 2016-2032

Table 17: MEA Market Value (US$ Mn) Forecast by Test Type, 2016-2032

Table 18: MEA Market Value (US$ Mn) Forecast by End User, 2016-2032

Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 1: Global Market Value (US$ Mn) by Test Type, 2022-2032

Figure 2: Global Market Value (US$ Mn) by End User, 2022-2032

Figure 3: Global Market Value (US$ Mn) by Region, 2022-2032

Figure 4: Global Market Value (US$ Mn) Analysis by Region, 2016-2032

Figure 5: Global Market Value Share (%) and BPS Analysis by Region, 2022-2032

Figure 6: Global Market Y-o-Y Growth (%) Projections by Region, 2022-2032

Figure 7: Global Market Value (US$ Mn) Analysis by Test Type, 2016-2032

Figure 8: Global Market Value Share (%) and BPS Analysis by Test Type, 2022-2032

Figure 9: Global Market Y-o-Y Growth (%) Projections by Test Type, 2022-2032

Figure 10: Global Market Value (US$ Mn) Analysis by End User, 2016-2032

Figure 11: Global Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 12: Global Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 13: Global Market Attractiveness by Test Type, 2022-2032

Figure 14: Global Market Attractiveness by End User, 2022-2032

Figure 15: Global Market Attractiveness by Region, 2022-2032

Figure 16: North America Market Value (US$ Mn) by Test Type, 2022-2032

Figure 17: North America Market Value (US$ Mn) by End User, 2022-2032

Figure 18: North America Market Value (US$ Mn) by Country, 2022-2032

Figure 19: North America Market Value (US$ Mn) Analysis by Country, 2016-2032

Figure 20: North America Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 21: North America Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 22: North America Market Value (US$ Mn) Analysis by Test Type, 2016-2032

Figure 23: North America Market Value Share (%) and BPS Analysis by Test Type, 2022-2032

Figure 24: North America Market Y-o-Y Growth (%) Projections by Test Type, 2022-2032

Figure 25: North America Market Value (US$ Mn) Analysis by End User, 2016-2032

Figure 26: North America Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 27: North America Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 28: North America Market Attractiveness by Test Type, 2022-2032

Figure 29: North America Market Attractiveness by End User, 2022-2032

Figure 30: North America Market Attractiveness by Country, 2022-2032

Figure 31: Latin America Market Value (US$ Mn) by Test Type, 2022-2032

Figure 32: Latin America Market Value (US$ Mn) by End User, 2022-2032

Figure 33: Latin America Market Value (US$ Mn) by Country, 2022-2032

Figure 34: Latin America Market Value (US$ Mn) Analysis by Country, 2016-2032

Figure 35: Latin America Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 36: Latin America Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 37: Latin America Market Value (US$ Mn) Analysis by Test Type, 2016-2032

Figure 38: Latin America Market Value Share (%) and BPS Analysis by Test Type, 2022-2032

Figure 39: Latin America Market Y-o-Y Growth (%) Projections by Test Type, 2022-2032

Figure 40: Latin America Market Value (US$ Mn) Analysis by End User, 2016-2032

Figure 41: Latin America Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 42: Latin America Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 43: Latin America Market Attractiveness by Test Type, 2022-2032

Figure 44: Latin America Market Attractiveness by End User, 2022-2032

Figure 45: Latin America Market Attractiveness by Country, 2022-2032

Figure 46: Europe Market Value (US$ Mn) by Test Type, 2022-2032

Figure 47: Europe Market Value (US$ Mn) by End User, 2022-2032

Figure 48: Europe Market Value (US$ Mn) by Country, 2022-2032

Figure 49: Europe Market Value (US$ Mn) Analysis by Country, 2016-2032

Figure 50: Europe Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 51: Europe Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 52: Europe Market Value (US$ Mn) Analysis by Test Type, 2016-2032

Figure 53: Europe Market Value Share (%) and BPS Analysis by Test Type, 2022-2032

Figure 54: Europe Market Y-o-Y Growth (%) Projections by Test Type, 2022-2032

Figure 55: Europe Market Value (US$ Mn) Analysis by End User, 2016-2032

Figure 56: Europe Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 57: Europe Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 58: Europe Market Attractiveness by Test Type, 2022-2032

Figure 59: Europe Market Attractiveness by End User, 2022-2032

Figure 60: Europe Market Attractiveness by Country, 2022-2032

Figure 61: Asia Pacific Market Value (US$ Mn) by Test Type, 2022-2032

Figure 62: Asia Pacific Market Value (US$ Mn) by End User, 2022-2032

Figure 63: Asia Pacific Market Value (US$ Mn) by Country, 2022-2032

Figure 64: Asia Pacific Market Value (US$ Mn) Analysis by Country, 2016-2032

Figure 65: Asia Pacific Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 66: Asia Pacific Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 67: Asia Pacific Market Value (US$ Mn) Analysis by Test Type, 2016-2032

Figure 68: Asia Pacific Market Value Share (%) and BPS Analysis by Test Type, 2022-2032

Figure 69: Asia Pacific Market Y-o-Y Growth (%) Projections by Test Type, 2022-2032

Figure 70: Asia Pacific Market Value (US$ Mn) Analysis by End User, 2016-2032

Figure 71: Asia Pacific Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 72: Asia Pacific Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 73: Asia Pacific Market Attractiveness by Test Type, 2022-2032

Figure 74: Asia Pacific Market Attractiveness by End User, 2022-2032

Figure 75: Asia Pacific Market Attractiveness by Country, 2022-2032

Figure 76: MEA Market Value (US$ Mn) by Test Type, 2022-2032

Figure 77: MEA Market Value (US$ Mn) by End User, 2022-2032

Figure 78: MEA Market Value (US$ Mn) by Country, 2022-2032

Figure 79: MEA Market Value (US$ Mn) Analysis by Country, 2016-2032

Figure 80: MEA Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 81: MEA Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 82: MEA Market Value (US$ Mn) Analysis by Test Type, 2016-2032

Figure 83: MEA Market Value Share (%) and BPS Analysis by Test Type, 2022-2032

Figure 84: MEA Market Y-o-Y Growth (%) Projections by Test Type, 2022-2032

Figure 85: MEA Market Value (US$ Mn) Analysis by End User, 2016-2032

Figure 86: MEA Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 87: MEA Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 88: MEA Market Attractiveness by Test Type, 2022-2032

Figure 89: MEA Market Attractiveness by End User, 2022-2032

Figure 90: MEA Market Attractiveness by Country, 2022-2032

July 2022
REP-GB-5276
301 pages
Healthcare

Book Now

CUSTOMIZE THIS RESEARCH

Which are the positive and negative factors impacting the Helicobacter Pylori Testing Market
How can you develop stable and lucrative revenue streams?
What will be your strategy to make top customers shift towards your brand?
Which significant steps can you take to stay ahead of competitors?
Get a complete personalized report with a scorecard of target partners

Customize Now